Y10S514/908 - CPC Classification Index

#1

20170281633

2017-10-05

Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith

#2

20140004082

2014-01-02

Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

#3

20120252861

2012-10-04

Medical compositions for intravesical treatment of bladder cancer

#4

20120064009

2012-03-15

Methods of leukemia cell detection

#5

20100081649

2010-04-01

Treatment of cancers with methylol-containing compounds and at least one electrolyte

#6

20100068314

2010-03-18

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#7

20090076123

2009-03-19

Medical Compositions for Intravesical Treatment of Bladder Cancer

#8

20080166402

2008-07-10

Medical compositions for intravesical treatment of bladder cancer

#9

20080161233

2008-07-03

Sustained Release Formulation of a Peptide

#10

20080019996

2008-01-24

MUSHROOM EXTRACTS HAVING ANTICANCER ACTIVITY

#11

20080014258

2008-01-17

Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases

#12

20070207119

2007-09-06

Histone deacetylase inhibitor enhancement of trail-induced apoptosis

#13

20070184131

2007-08-09

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#14

20070149572

2007-06-28

Method of inhibiting FLT3 kinase

#15

20070010570

2007-01-11

Medical Compositions for Intravesical Treatment of Bladder Cancer

#16

20060183729

2006-08-17

Vanadium compounds as anti-angiogenic agents

#17

20060160792

2006-07-20

Treatment of cancers with methylol-containing compounds and at least one electrolyte

#18

20060135513

2006-06-22

Methods of treating tumors

#19

20060057157

2006-03-16

Mushroom extracts having anticancer activity

#20

20060045887

2006-03-02

Mushroom extracts having anticancer activity

#21

20050215615

2005-09-29

Medical compositions for intravesical treatment of bladder cancer

#22

20050191367

2005-09-01

Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds

#23

20050130952

2005-06-16

Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases

#24

20050119254

2005-06-02

Treatment of mesothelioma

#25

20050107287

2005-05-19

Treatment of cancers by inhalation of stable platinum-containing formulations

#26

20050100611

2005-05-12

Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds

#27

20050089585

2005-04-28

Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof

#28

20050089576

2005-04-28

Sustained release formulation of a peptide